Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transitional Cell, Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06221774
What this trial is testing

Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors

Who this might be right for
Clear Cell Renal CarcinomaUrothelial CarcinomaMetastatic Castration-resistant Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 42
Testing effectiveness (Phase 2)Looking for participantsNCT04678362
What this trial is testing

TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Centre Francois Baclesse 50
Testing effectiveness (Phase 2)Looking for participantsNCT06696742
What this trial is testing

PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
The First Affiliated Hospital with Nanjing Medical University 60
Testing effectiveness (Phase 2)Ended earlyNCT03185468
What this trial is testing

Intervention of Bladder Cancer by CAR-T

Who this might be right for
Bladder CancerUrothelial Carcinoma Bladder
Shenzhen Geno-Immune Medical Institute 20
Early research (Phase 1)Study completedNCT02808143
What this trial is testing

Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Recurrent Bladder CarcinomaStage 0a Bladder Urothelial CarcinomaStage 0is Bladder Urothelial Carcinoma+1 more
Northwestern University 9
Not applicableStudy completedNCT05154084
What this trial is testing

RESECT: Improving Quality in TURBT Surgery.

Who this might be right for
Bladder Cancer
British Urology Researchers in Surgical Training 19,505
Not applicableStudy completedNCT02246738
What this trial is testing

Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer Cohorts

Who this might be right for
Urothelial Carcinoma of the Bladder
Abramson Cancer Center at Penn Medicine 87
Early research (Phase 1)Looking for participantsNCT07518043
What this trial is testing

HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors

Who this might be right for
Esophageal and/or Cardia CancerMelanomaUrothelial Carcinoma (UC)
Shanghai Henlius Biotech 174
Large-scale testing (Phase 3)Ended earlyNCT00384891
What this trial is testing

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

Who this might be right for
Urinary Bladder DiseasesUrinary Bladder NeoplasmsUrinary Bladder Cancer+5 more
Medical Enterprises Europe B.V. 190
Testing effectiveness (Phase 2)Study completedNCT00006376
What this trial is testing

R115777 in Treating Patients With Advanced Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Study completedNCT03190174
What this trial is testing

Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

Who this might be right for
Ewing SarcomaPEComaEpithelioid Sarcoma+11 more
Sarcoma Oncology Research Center, LLC 34
Not applicableLooking for participantsNCT07630155
What this trial is testing

Office-Based Ureteroscopy Utilizing a Single Use Digital, Flexible Ureteroscope for Upper Tract Urothelial Carcinoma

Who this might be right for
Renal Pelvis and Ureter Urothelial Carcinoma
University of Michigan Rogel Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT03241173
What this trial is testing

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced Malignancies
Incyte Biosciences International Sàrl 52
Testing effectiveness (Phase 2)Study completedNCT02178241
What this trial is testing

Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery

Who this might be right for
Metastatic Ureter CarcinomaMetastatic Urethral CarcinomaStage III Bladder Urothelial Carcinoma AJCC v6 and v7+7 more
National Cancer Institute (NCI) 26
Not applicableStudy completedNCT03013894
What this trial is testing

Confocal Laser Endomicroscopy in the Lower Urinary Tract

Who this might be right for
Bladder NeoplasmUrothelial Carcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 73
Testing effectiveness (Phase 2)Study completedNCT02788201
What this trial is testing

Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaBladder CancerUrinary Bladder Neoplasms
National Cancer Institute (NCI) 8
Not applicableWithdrawnNCT02944357
What this trial is testing

Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery

Who this might be right for
Infiltrating Bladder Urothelial CarcinomaStage II Bladder Urothelial CarcinomaStage III Bladder Urothelial Carcinoma+1 more
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT00045630
What this trial is testing

S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
SWOG Cancer Research Network 77
Not applicableUnknownNCT06113367
What this trial is testing

Immunotherapy in Upper Tract Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Assistance Publique - Hôpitaux de Paris 350
Testing effectiveness (Phase 2)Looking for participantsNCT07183319
What this trial is testing

Circulating Tumor DNA Response In Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
University of Oklahoma 30
Next Page